Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ty's "seven-day average of new cases has hit 645, up dramatically from where the city was at the start of the month." The Chicago Sun-Times (10/22, Spielman, 875K) reports Lightfoot "openly acknowledged the tremendous hardship on restaurants and bars that are the lifeblood of Chicago neighborhoods." Sai

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

/chicago.suntimes.com/coronavirus/2020/10/22/21528535/coronavirus-covid- chicago-bars-indoor-service-restaurants-businesses-curfew-lightfoot> (10/22, Spielman, 875K) reports Lightfoot "openly acknowledged the tremendous hardship on restaurants and bars that are the lifeblood of Chicago neighborhoods." Sai

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ty's "seven-day average of new cases has hit 645, up dramatically from where the city was at the start of the month." The Chicago Sun-Times (10/22, Spielman, 875K) reports Lightfoot "openly acknowledged the tremendous hardship on restaurants and bars that are the lifeblood of Chicago neighborhoods." Sai